Introduction
BYBO Health AI turns a 16‑minute paperwork sinkhole into a 2‑minute audit‑proof note, freeing 10 billable hours per clinician every week.
- Regulatory‑aware NLP auto‑generates ASAM‑aligned notes.
- Immutable audit logs eliminate claw‑back risk.
- Competitive pricing undercuts Nuance DAX ($600/mo) by more than 60%.
Founded by Rickey J. Green, a 19-year industry leader and appointed member of the Kentucky Governor’s Advisory Council for Recovery Ready Communities. BYBO begins with unprecedented direct access to key decision-makers across Kentucky’s addiction treatment ecosystem.
“The product is literally primed and waiting on me to make the announcement.” — Rickey J. Green, Founder
Our pre-established government relationships and industry expertise create an immediate credibility advantage, dramatically reducing customer acquisition costs and accelerating adoption cycles.
Founder Advantage
Kentucky Government Relationships
- Governor’s Advisory Council: 1 of 13 members on Recovery Ready Communities initiative
- Judicial System: Chairperson for Restorative Justice, working directly with county attorneys and Supreme Court Justice Bisig
- Legislative Allies: Collaboration with US Senators Westerfield and Herron
- Executive Access: Personal relationship with Kentucky Governor Andy Beshear
Industry Leadership
- VOA Mid-States: 7-year Board of Directors member and Program & Public Policy Committee service
- Consultant: Specialized in auditing residential substance use treatment centers in Kentucky
- Documentation Expertise: Evaluated and optimized documentation processes for increased staff efficiency
- Market Entry Acceleration: Established relationships minimize typical go-to-market friction points
- Decision-Maker Access: Direct connections to treatment center leadership across Kentucky
- Regulatory Insight: Firsthand experience with documentation audit requirements
- Implementation Expertise: Deep understanding of residential facility operations and staff workflows
- Advisory Network: Access to key government stakeholders for product alignment with policy initiatives
These relationships provide BYBO Health AI with a rare competitive advantage: a founder-led pathway to immediate pilot deployments across multiple Kentucky treatment facilities, bypassing traditional barriers to adoption in healthcare settings.
Market Opportunity
14,000 residential clinicians × blended $54k ARR. HB 695 mandates scorecard reporting & tightens prior‑auth, forcing centers to modernize documentation.
Product & Tech
- React Native mobile + responsive web dashboard.
- FastAPI microservices + GPT‑4 & Whisper inference.
- HIPAA cloud with SOC 2 & zero‑trust encryption.
Top Pain Points
| Pain | Operational Hit | BYBO Fix |
|---|---|---|
| 35% time lost to notes | Burnout, lost revenue | <2 min AI note |
| Audit failures (OIG) | Claw‑backs, denials | Immutable audit trail |
| $600 DAX seats | Unsustainable spend | $249 Essential tier |
| Duplication of info | Inefficient workflows | Single-source data |
Go To Market
BYBO’s go-to-market strategy leverages Rickey Green’s extensive government relationships and industry position to create an unprecedented fast-track to deployment:
- Phase 1: Kentucky Advantage — Utilize founder’s Advisory Council position and relationships with decision-makers to secure initial pilot deployments
- Phase 2: Government-Backed Expansion — Leverage HB 695 compliance requirements and Recovery Ready Communities initiative to drive adoption
- Phase 3: Regional Scale — Expand to neighboring states through established industry connections and demonstrated Kentucky success
This founder-advantage strategy creates a unique market entry position where facilities are “literally primed and waiting for the announcement” – bypassing traditional healthcare sales cycles.
- Initial Focus: Kentucky residential treatment facilities with direct founder connections (VOA Mid-States and others)
- Channel Partners: Direct introduction through Governor’s Advisory Council and Recovery Ready Communities initiative
- Land + Expand: Free pilot → Departmental → Enterprise deployment, facilitated by pre-existing relationships
Financials
| Year | Clinicians | Revenue | Costs | Gross Profit | Margin |
|---|---|---|---|---|---|
| Year 1 | 50 | $287,400 | $373,000 | -$85,600 | -30% |
| Year 2 | 150 | $897,114 | $630,000 | $267,114 | 30% |
| Year 3 | 300 | $1,823,700 | $910,000 | $913,700 | 50% |
Break-even: Month 18
| Year | Infrastructure | Labor | Tooling | HIPAA/Security | Total |
|---|---|---|---|---|---|
| Year 1 | $20,000 | $300,000 | $3,000 | $50,000 | $373,000 |
| Year 2 | $50,000 | $500,000 | $5,000 | $75,000 | $630,000 |
| Year 3 | $100,000 | $700,000 | $10,000 | $100,000 | $910,000 |
Infrastructure trend reflects rising cloud OPEX but stays below $333/clinician in Year 1.
Founder’s government and industry relationships create significant CAC advantages:
- Traditional Healthcare SaaS: $8,000-12,000 customer acquisition cost
- BYBO’s Founder Advantage: Projected 30-40% reduction in CAC due to pre-established relationships and government council position
- Accelerated Sales Cycle: 3-4x faster time-to-close with facilities already “primed and waiting”
Revenue Flow
| Tier | Base Price | Session Fee | Avg Sessions/mo | Available Discounts |
|---|---|---|---|---|
| Essential | $249/month | $5/session | 40 | Annual pre-pay |
| Professional | $349/month | $5/session | 50 | 10% volume discount |
| Enterprise | $299/clinician | $5/session | 50 | 15-20% volume discount |
Reference: Nuance DAX pricing ≈ $600 per seat/month
| Tier | Clinicians | Sub $/mo | Sessions/mo | MRR sub | MRR sess | MRR total |
|---|---|---|---|---|---|---|
| Essential | 40 | 249 | 40 | $9,960 | $8,000 | $17,960 |
| Professional | 10 | 349 | 50 | $3,490 | $2,500 | $5,990 |
| Total | 50 | $13,450 | $10,500 | $23,950 |
Annual revenue: $287,400
| Tier | Clinicians | Effective Price | Sessions/mo | Annual Sub | Annual Sess | Annual Total |
|---|---|---|---|---|---|---|
| Essential | 70 | 249 | 40 | $209,160 | $168,000 | $377,160 |
| Professional | 50 | 314 (10% disc) | 50 | $188,460 | $150,000 | $338,460 |
| Enterprise | 30 | 254 (15% disc) | 50 | $91,494 | $90,000 | $181,494 |
| Total | 150 | $489,114 | $408,000 | $897,114 |
| Tier | Clinicians | Effective Price | Sessions/mo | Annual Sub | Annual Sess | Annual Total |
|---|---|---|---|---|---|---|
| Essential | 100 | 249 | 40 | $298,800 | $240,000 | $538,800 |
| Professional | 100 | blend (50 no disc/50 10%) | 50 | $397,860 | $300,000 | $697,860 |
| Enterprise | 100 | 239 (20% disc) | 50 | $287,040 | $300,000 | $587,040 |
| Total | 300 | $983,700 | $840,000 | $1,823,700 |
Risk Assessment
| Variable | -10% Scenario | +15% Cost Scenario |
|---|---|---|
| Session volume | -$41k Y2 revenue; profit still +$226k | Shifts break-even by <1 quarter |
| Discount creep | Extra 5% across tiers → -$49k Y3 ARR | Mitigate via annual pre-pay |
| Risk | Severity | Mitigation Strategy |
|---|---|---|
| Regulatory changes | Medium | Founder’s government relationships provide early insight |
| Enterprise AI competition | Medium | Vertical-specific features + founder relationships as moat |
| EHR vendor blockage | Medium | Direct integrations, browser extension |
| User adoption friction | Low | Guided onboarding, 2-week ROI guarantee |
Regulatory note: HIPAA overhaul (proposed Dec 2024) could add $9B cost to sector but favors turnkey-compliance vendors
HB 695 Impact
House Bill 695 introduces several key requirements creating tailwinds for BYBO adoption:
- Mandatory Compliance Scorecard: BYBO automates reporting
- Stricter Prior Authorization: Our audit-proof notes reduce denials
- Quality Metrics: Our analytics dashboard tracks & improves scores
As a member of the Governor’s Advisory Council and working relationship with key legislators, founder Rickey Green has unique insight into implementation timelines and compliance nuances that competitors lack.
Conclusion
- Problem: Documentation burden costs clinics 30%+ of billable time
- Solution: AI-powered, regulatory-aware note system saves 10+ hours weekly
- Founder Advantage: 19-year industry leader with key government positions and direct access to decision-makers
- Opportunity: $750M TAM with industry tailwinds from HB 695
- Differentiation: Purpose-built for addiction medicine, 60% lower cost than competitors
- Financial: Break-even at month 18 with 50% gross margin by Year 3
BYBO Health AI represents a rare opportunity where product-market fit, founder expertise, and government relationships converge to create an accelerated path to market adoption with facilities “literally primed and waiting” for launch.